The Impact of Medicaid Preferred Drug Lists on Utilization and Costs of Antipsychotic Medication by Christian Frois, Thomas O’Connell, Jacqueline Pesa, John Fastenau

“…For each program, the total antipsychotic cost per capita was estimated by multiplying antipsychotic utilization by list price (First DataBank), then dividing by program enrollment. …”
Get full text